Pharmafile Logo
Pharmafocus logo
Advanced Search

Lantus

Showing 6 posts of 21 posts found.

nhsscaffoldingcover_18

Cost of diabetes treatment soars in England

August 13, 2014
Medical Communications, Research and Development, Sales and Marketing Lantus, NHS, Sanofi, diabetes

The NHS spent more than £2.2 million on average every day over the last financial year on diabetes medicines, according …

News
Lilly image

Sanofi files Lilly lawsuit

February 3, 2014
Sales and Marketing FDA, Lantus, Sanofi, lilly

A row which has been brewing between Sanofi and Eli Lilly & Company has now erupted with the French manufacturer …

News
Sanofi image

New insulin scores for Sanofi

December 5, 2013
Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300

Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …

News
Pfizer picture

Pfizer pulls out of $350 million insulin pact

March 14, 2012
Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …

News

No cancer link with Lantus, says Sanofi

December 7, 2011
Sales and Marketing Cancer, Lantus, Sanofi, diabetes, insulin, safety

Sanofi has presented a new meta-analysis which suggests its insulin blockbuster Lantus does not raise the risk of cancer. A …

News

Sanofi picks two agencies for UK diabetes account

February 25, 2011
Medical Communications Lantus, Sanofi-Aventis, Tudor Reilly, diabetes, medical communications account win, red health

Healthcare PR agencies Tudor Reilly and Red Health have jointly won the Sanofi-Aventis UK diabetes account after a five-way pitch. …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026